Skip to main content
logo
Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India flag India · Delayed Price · Currency is INR
1,994.90
-4.80 (-0.24%)
Jan 28, 2026, 3:20 PM IST

Glenmark Pharmaceuticals Revenue

Glenmark Pharmaceuticals had revenue of 60.47B INR in the quarter ending September 30, 2025, with 76.10% growth. This brings the company's revenue in the last twelve months to 159.97B, up 22.30% year-over-year. In the fiscal year ending March 31, 2025, Glenmark Pharmaceuticals had annual revenue of 133.63B with 5.68% growth.

Revenue (ttm)
159.97B
Revenue Growth
+22.30%
P/S Ratio
3.53
Revenue / Employee
10.12M
Employees
15,800
Market Cap
564.32B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025133.63B7.18B5.68%
Mar 31, 2024126.45B9.90B8.49%
Mar 31, 2023116.56B-6.49B-5.28%
Mar 31, 2022123.05B13.61B12.44%
Mar 31, 2021109.44B2.87B2.69%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Aurobindo Pharma325.14B
Cipla279.67B
Zydus Lifesciences244.94B
Alkem Laboratories138.90B
Mankind Pharma135.46B
Ipca Laboratories93.59B
Emcure Pharmaceuticals84.49B
Laurus Labs67.22B
Revenue Rankings

Glenmark Pharmaceuticals News

More News